Gender Dysphoria
On this page
Direct answer
Gender dysphoria (DSM-5) is distress from a marked incongruence between one's experienced or expressed gender and assigned gender, lasting at least six months in adolescents and adults and associated with clinically significant distress or impairment — the diagnosis was renamed from gender identity disorder, and ICD-11 removed the phenomenon from mental disorders altogether, classifying gender incongruence under conditions related to sexual health. In children the diagnosis requires at least six of eight indicators with onset around early childhood; in adolescents, pubertal suppression with a gonadotropin-releasing hormone agonist at Tanner stage 2-3, later cross-sex hormone therapy (commonly from about age 16), and gender-affirming surgery in adulthood follow comprehensive assessment per World Professional Association for Transgender Health standards. Indian law recognises transgender persons through the NALSA judgement of 2014 and the Transgender Persons (Protection of Rights) Act, 2019.
What you must remember
- Name changes, classification splits: DSM-IV gender identity disorder became DSM-5 gender dysphoria (distress-based, to avoid pathologising identities), while ICD-11's gender incongruence sits outside mental disorders — a guaranteed marks question.
- Adolescent-adult criteria (DSM-5): marked incongruence between experienced and assigned gender for at least six months, with at least two of six indicators — strong desire to be of the other gender, or to be treated as such, or to have the primary or secondary sex characteristics of the other gender, or to be rid of one's own characteristics — plus distress or impairment.
- Children's criteria: at least six of eight indicators (including strong preferences for cross-gender roles, toys, playmates, and stated desire to be the other gender), onset before about age 10, with distress or impairment.
- Prepubertal management: watchful waiting versus supporting social transition, since childhood gender dysphoria desists in a majority by adolescence in older follow-up studies — a contested figure viva boards may probe; persistence into early puberty predicts adolescent-adult dysphoria.
- Adolescent medical pathway: GnRH agonist (for example leuprolide) pubertal suppression at Tanner 2-3 (reversible), cross-sex hormones commonly from about 16, and surgeries typically in adulthood, each after capacity assessment and informed consent under WPATH standards of care.
- Mental health tasks: assess and treat depression, anxiety and self-harm (rates driven substantially by stigma and minority stress), support the family, and never offer conversion therapy — condemned by professional bodies.
- Indian legal scaffold: the NALSA judgement (2014) recognised the third gender; the Transgender Persons (Protection of Rights) Act, 2019 provides for certificate of identity.
Walking an adolescent assessment pathway
A 15-year-old assigned female at birth has insisted since age 11 that he is a boy, binds his chest, uses a male name at school, and was brought in after self-harm following ridicule. Assessment proceeds on two axes. The first is gender: the dysphoria criteria — six months and more of a strong desire to be treated as male and to be rid of breast development — with history taken from the young person alone, corroborated by school and family; the second is mental state, treating the depression and self-harm risk now, because safety is not contingent on the gender pathway. He is at Tanner stage 3, so the GnRH agonist question is live: after multidisciplinary review and informed consent, pubertal suppression begins, buying time with a reversible intervention while cross-gender hormone decisions mature toward about age 16.
The viva layer is the family. Parents grieving the daughter they imagined need their own psychoeducation, the school needs guidance on name and toilets, and every consent is documented — Indian surgery pathways under the 2019 Act and WPATH standards both demand capacity and persistence.
Where students slip
The pure recall items are the renamings and the move: "gender identity disorder" is a DSM-IV label; ICD-11 does not classify gender incongruence as a mental disorder at all — candidates who miss that answer classification questions backwards. The criteria numbers are the next trip: six months, two of six indicators in adolescents and adults, six of eight in children. In management stems, the sequence is the answer — pubertal suppression first at Tanner 2-3, hormones later, surgery last — and "conversion therapy to align identity with assigned gender" is always wrong. A subtler mark-earner is aetiological honesty: dysphoria's origins are not established, and stating the uncertainty beats reciting either pole. Indian context: the NALSA judgement and the 2019 Act are the legal pair to cite, and hijra and kinnar communities provide the cultural frame within which care must be respectful and non-pathologising.
Frequently asked questions
How does ICD-11 classify gender incongruence?
Not as a mental disorder — it is placed under conditions related to sexual health, whereas DSM-5 retains gender dysphoria within mental disorders with a distress-based definition.
What are the DSM-5 duration and threshold rules?
At least six months of marked incongruence, with at least two of six indicators in adolescents and adults and six of eight indicators in children.
What is pubertal suppression and when is it offered?
Gonadotropin-releasing hormone agonists given at Tanner stage 2-3 to pause puberty reversibly, after multidisciplinary assessment, buying time before decisions on cross-sex hormones.
Which Indian laws frame transgender healthcare?
The NALSA Supreme Court judgement of 2014 recognising the third gender, and the Transgender Persons (Protection of Rights) Act, 2019 providing identity certification and protection.
Is conversion therapy an acceptable treatment?
No — attempts to change gender identity are condemned by professional bodies; care supports the person's identified gender trajectory with assessment, comorbidity treatment and informed consent.